Who
Dimension Capital II, L.P.
Director
Company insider
Files Form 4 as: Director, Odyssey Therapeutics.
In numbers
- Trades disclosed
- 6
- Buys
- 1
- Sells
- 0
- Bought
- $40.0M
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 8 May 2026
- Last trade
- 8 May 2026
- Last filed
- 12 May 2026
Companies traded
Activity over time
1 May – 1 Oct
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 8 May 2026filed 12 May 2026 | ODTX Odyssey TherapeuticsBiotechnology | SEC FORM 4 Code C | —1,709,543 | filing |
| 8 May 2026filed 12 May 2026 | ODTX Odyssey TherapeuticsBiotechnology | SEC FORM 4 Bought | $20.0M1,111,111 at $18.00 | filing |
| 8 May 2026filed 12 May 2026 | ODTX Odyssey Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code C | —16,611,626 | filing |
| 8 May 2026filed 12 May 2026 | ODTX Odyssey Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code C | —16,611,626 | filing |
| 8 May 2026filed 12 May 2026 | ODTX Odyssey TherapeuticsBiotechnology | SEC FORM 4 Code C | —1,709,543 | filing |
| 8 May 2026filed 12 May 2026 | ODTX Odyssey TherapeuticsBiotechnology | SEC FORM 4 Bought | $20.0M1,111,111 at $18.00 | filing |
News
Odyssey Therapeutics Announces Encouraging Phase 2a Ulcerative Colitis ResultsODTX · rttnews.com · 20 Oct 2026
0 headlines in the last 90 days name Dimension Capital II, L.P.; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.